SAN DIEGO, Sept. 25 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences will present at the UBS Global Life Sciences Conference. The live presentation takes place Tuesday, September 26, 2006 at 4:00 p.m. Eastern Time (ET)/1:00 p.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company’s website at http://www.neurocrine.com
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Woodworth or Elizabeth Foster. A replay will become available approximately three hours after the live event concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived for fourteen days.
About Neurocrine
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com
Neurocrine Biosciences, Inc.
CONTACT: Claudia Woodworth or Elizabeth Foster, both of NeurocrineBiosciences, Inc., +1-858-617-7600
Web site: http://www.neurocrine.com/
